1AI
Algorae Pharmaceuticals Limited
🇦🇺 ASX
🧬 BIOTECHNOLOGY
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-10.67%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
3
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Algorae Pharmaceuticals Ltd. is a biotechnology company, which engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-01. The firm is actively engaged in expanding its therapeutic pipeline using a proprietary artificial intelligence (AI) drug discovery and development platform, known as Algorae Operating System (AlgoraeOS). The AI platform leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. By employing machine learning, deep learning, and neural networks, the AlgoraeOS is focused on uncovering synergistic fixed dose drug combinations that lead to the development of effective treatments for any medical condition. The company is also focused on advancing its drug candidates, which include AI-116 for the treatment of neurodegenerative disorders and/or dementia, and AI-168 for cardiovascular disease and NTCELL for Parkinson’s disease.
📈 Performance
Price History
-88.71%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in 1AI
3
📊 Total Capital Earnings
$1K
🔃 Average investment frequency
7 days
💵 Average investment amount
$5,180
⏰ Last time a customer invested in 1AI
23 days
1AI investor breakdown
💵 Income of investors
More than 200k
150k - 200k
25%
100k - 150k
50%
50k - 100k
Less than 50k
25%
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
33%
Male
67%
Pearlers who invest in 1AI also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.63%
📊 Share price
$102.10 AUD
🇦🇺 AUSTRALIA
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
14.07%
📊 Share price
$140.20 AUD
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🌏 GLOBAL
🤖 TECHNOLOGY
Living Cell Technologies Ltd. is a biotechnology company, which engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-01. The firm is focused on discovering and developing treatments for conditions, such as diabetes and Parkinson's disease. The company operates in both Australia and New Zealand, being the research and development and product development into living cell technologies. The firm's product candidate includes NTCELL, an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells targeting Parkinson’s disease. Choroid plexus cells are naturally occurring support cells for the brain and secrete cerebrospinal fluid (CSF), which contains a range of factors that support nerve cell functions and protective enzymes that are crucial for nerve growth and healthy functioning. In NTCELL, the porcine choroid plexus cells are coated with LCT's technology IMMUPEL to protect them from attack by the immune system. The firm has completed two clinical trials of NTCELL in Parkinson's disease.
📊 Share price
$0.01 AUD
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
🙌 Performance (5Yr p.a)
13.69%
📊 Share price
$87.01 AUD
🌏 GLOBAL
🛍️ CONSUMER
📈 HIGH PRICE GROWTH
🏭 INDUSTRIALS
Want more shares? Try these...
Aurora Energy Metals Ltd. engages in the exploration and development of mining properties. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2022-05-18. The AUP is located in Malheur County, Oregon, approximately 16 kilometers (km) northwest of the town of McDermitt, Nevada. The Company’s wholly owned subsidiary, Oregon Energy LLC, holds 100% of the Project as well as surrounding mining claims that extend to the west and to the south-east, across the Oregon/Nevada border. The mining claims are located on public lands in Oregon and Nevada and on a contiguous Company-owned block of private land in Nevada. The land tenure comprises approximately 451 unpatented lode mining claims and 71 unpatented placer mining claims in Malheur County, Oregon and 31 unpatented placer mining claims in Humboldt County, Nevada. The total area covered by these claims is approximately 43 square kilometers. The Project area is covered with a thin veneer of alluvium overlying lakebed sediments.
📊 Share price
$0.05 AUD
⛏️ MINING
Alterra Ltd. is a horticultural project developer, which focuses on the development of its Carpenters avocado project in Western Australia. The company is headquartered in Perth, Western Australia. The company went IPO on 2008-05-16. The firm is a developer of the Carpenters Avocado Project located between Manjimup and Pemberton in Western Australia’s south-west. The Carpenters Project consists of circa 100 hectares (ha) of Hass avocados. The Carpenters Project is a 200-hectare avocado development located near Pemberton, Western Australia, 3.5 hours south of Perth. Its Asset Management segment relates to the management of operating assets, including the contract to manage the demerged Carbon Business. Its Asset Development segment relates to assets owned or being developed by the Company. Its Business Development segment relates to the development of potential assets. The firm also holds a 15% direct interest in Carbon Conscious Investments Limited (CCIL), which manages large scale projects registered with the clean energy regulator that generate Australian Carbon Credit Units.
🙌 Performance (5Yr p.a)
-17.19%
📊 Share price
$0.01 AUD
🍔 FOOD PRODUCTS